MAIA Biotechnology Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for MAIA Biotechnology in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for MAIA Biotechnology.

Recommendation Trends

Rating	Feb '23
Strong Buy	0
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert LeBoyer Noble Capital Markets	Noble Capital Markets	Buy Initiates $14	Buy	Initiates	$14	+968.70%	Feb 21, 2023

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

404.48M

EPS This Year

-0.70

from -0.70

EPS Next Year

n/a

from -0.70

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2028
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2028
Revenue	-	-	-	-	-	-	404.48M
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.37	-1.75	-1.49	-1.05	-0.70	-0.70	-
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2028
High	n/a	416.4M
Avg	n/a	404.5M
Low	n/a	388.6M

Revenue Growth

Revenue Growth	2026	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026
High	-0.72
Avg	-0.70
Low	-0.68

EPS Growth

EPS Growth	2026
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.